Antibiotic susceptibility in prostate-derived Propionibacterium acnes isolatesShow others and affiliations
2012 (English)In: Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS), ISSN 0903-4641, E-ISSN 1600-0463, Vol. 120, no 10, p. 778-785Article in journal (Refereed) Published
Abstract [en]
The aim of this study was to determine antibiotic susceptibility of Propionibacterium acnes isolates from prostate. Prostate-derived P. acnes isolates (n = 24, Umea & Orebro, Sweden, 20072010) and a panel of control strains (n = 25, Sweden) collected from skin and deep infections were assessed for resistance to penicillin G, piperacillintazobactam, imipenem, gentamicin, azithromycin, erythromycin, vancomycin, ciprofloxacin, moxifloxacin, tetracycline, tigecycline, fusidic acid, clindamycin, rifampicin, linezolid, daptomycin, trimethoprimsulfamethoxazole, and metronidazole. In addition, the isolates were tested for inducible clindamycin resistance. All prostate derived P. acnes isolates displayed wild-type distribution of MIC-values, without evidence of acquired resistance. In the reference panel, 5 of 25 isolates had acquired macrolide resistance with cross-resistance to azithromycin, clindamycin, and erythromycin. In addition, one of these isolates was resistant to tetracycline.
Place, publisher, year, edition, pages
2012. Vol. 120, no 10, p. 778-785
Keywords [en]
Antibiotic, Cancer, Propionibacterium, Prostate, Prostatitis
National Category
Infectious Medicine
Research subject
Medicine
Identifiers
URN: urn:nbn:se:oru:diva-42796DOI: 10.1111/j.1600-0463.2012.02905.xISI: 000308578200002PubMedID: 22958285Scopus ID: 2-s2.0-8486615041OAI: oai:DiVA.org:oru-42796DiVA, id: diva2:789477
Note
Funding Agencies:
County Council of Vasterbotten (ALF)
Medical Faculty of Umeå University
Lions Cancer Research Foundation
Cancerforskningsfonden Norrland
Svenska Läkaresällskapet SLS-173871
2015-02-192015-02-192024-03-04Bibliographically approved